Featured Programs
Highlights from the 2014 ASH Annual Meeting
Laura Jones recaps major findings and experts discuss ruxolitinib as a treatment for patients with polycythemia vera. View Now
Recent Advances in MDS and CML
Moderated by Leonard S. Sender, MD, this panel discussion focuses on therapies for different subgroups of acute lymphocytic leukemia, with input from Dan Douer, MD, Jeffrey Lancet, MD, Mark R. Litzow, MD, and Raoul Tibes, MD, PhD. View Now

Most Popular Right Now
$auto_registration$